Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler?
Aerosol
Inhalation flow pattern
Particle diameter
Pressurized metered dose inhaler
Journal
AAPS PharmSciTech
ISSN: 1530-9932
Titre abrégé: AAPS PharmSciTech
Pays: United States
ID NLM: 100960111
Informations de publication
Date de publication:
06 Jan 2020
06 Jan 2020
Historique:
received:
09
09
2019
accepted:
12
12
2019
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
4
6
2020
Statut:
epublish
Résumé
To achieve adequate inhalation therapy, a proper inhalation technique is needed in clinical practice. However, there is limited information on proper inhalation flow patterns of commercial inhalers. Here, we quantitatively estimated airway deposition of two commercial pressurized metered dose inhalers (pMDIs) to determine their optimal inhalation patterns. Sultanol
Identifiants
pubmed: 31907655
doi: 10.1208/s12249-019-1610-x
pii: 10.1208/s12249-019-1610-x
doi:
Substances chimiques
Albuterol
QF8SVZ843E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
53Références
Laube BL, Janssens HM, De Jongh FHC, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–31.
doi: 10.1183/09031936.00166410
Hira D, Okuda T, Kito D, Ishizeki K, Okada T, Okamoto H. Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns. Pharm Res. 2010;27:2131–40.
doi: 10.1007/s11095-010-0215-6
Laube BL, Norman PS, Adams GK. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. J Allergy Clin Immunol. 1992;89:510–8.
doi: 10.1016/0091-6749(92)90317-U
Hira D, Okuda T, Mizutani A, Tomida N, Okamoto H. In vitro evaluation of optimal inhalation flow patterns for commercial dry powder inhalers and pressurized metered dose inhalers with human inhalation flow pattern simulator. J Pharm Sci. 2018.
Hira D, Koide H, Nakamura S, Okada T, Ishizeki K, Yamaguchi M, et al. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices. PLoS One. 2018;13.
van Aalderen WMC, Grigg J, Guilbert TW, Roche N, Israel E, Martin RJ, et al. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma. J Allergy Clin Immunol Pract [Internet]. Elsevier Inc; 2015;3:721–731.e16. Available from: https://doi.org/10.1016/j.jaip.2015.04.012
Colice G, Martin RJ, Israel E, Roche N, Barnes N, Burden A, et al. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone. J Allergy Clin Immunol [internet]. 2013 [cited 2018 Sep 28]. 132:45–54.e10 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23591272 .
Watling CP, Elliott JA, Cameron RE. Entrainment of lactose inhalation powders: A study using laser diffraction. Eur J Pharm Sci [Internet]. Elsevier B.V.; 2010;40:352–358. Available from: https://doi.org/10.1016/j.ejps.2010.04.009
Heyder J. Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc. 2004;1:315–20.
doi: 10.1513/pats.200409-046TA
Global Strategy for Asthma Management and Prevention (2019 update) [Internet]. Glob. Initiat. Asthma. 2019. Available from: http://www.ginasthma.org
Global Initiative for Chronic Obstructive Lung Disease (2019 Report) [Internet]. 2019. Available from: www.goldcopd.org
Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, et al. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet [internet]. Elsevier Ltd. 2016;388:963–73. Available from:. https://doi.org/10.1016/S0140-6736(16)31354-X .
doi: 10.1016/S0140-6736(16)31354-X